Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Berger

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Antioxidants (Basel, Switzerland)|February 24, 2024
The Antioxidant and Anti-Inflammatory Properties of Wild Bilberry Fruit Extracts Embedded in Mesoporous Silica-Type Supports: A Stability StudyAna-Maria Brezoiu, Mihaela Deaconu, Raul-Augustin Mitran, et al.
Antioxidants (Basel, Switzerland)|August 7, 2020
Effect of Nanoconfinement of Polyphenolic Extract from Grape Pomace into Functionalized Mesoporous Silica on Its Biocompatibility and Radical Scavenging ActivityAna-Maria Brezoiu, Laura Bajenaru, Daniela Berger, et al.
Nanoscale|August 24, 2022
Evaluation of intracellular distribution of folate functionalized silica nanoparticles using fluorescence and hyperspectral enhanced dark field microscopyLuminita Claudia Miclea, Mona Mihailescu, Nicolae Tarba, et al.
Pharmaceutics|September 5, 2020
Biological Evaluation of Black Chokeberry Extract Free and Embedded in Two Mesoporous Silica-Type MatricesValentina Buda, Ana-Maria Brezoiu, Daniela Berger, et al.
Veterinary and Comparative Oncology|April 12, 2017
The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytomaAlexandra Keller, Bettina Wingelhofer, Barbara Peter, et al.
Oncotarget|October 6, 2017
The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cellsGabriele Stefanzl, Daniela Berger, Sabine Cerny-Reiterer, et al.
Leukemia|March 15, 2023
Engraftment in NSG<sub>SCF</sub> mice correlates with the WHO category and prognosis in systemic mastocytosisMichael Willmann, Barbara Peter, Katharina Slavnitsch, et al.
American Journal of Cancer Research|October 18, 2021
Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing <i>BCR-ABL1</i> <sup>T315I</sup>-compound mutationsKaroline V Gleixner, Yüksel Filik, Daniela Berger, et al.
Leukemia|April 7, 2019
Identification of a leukemia-initiating stem cell in human mast cell leukemiaGregor Eisenwort, Irina Sadovnik, Juliana Schwaab, et al.
The Journal of Allergy and Clinical Immunology|August 11, 2022
Expression and regulation of Siglec-6 (CD327) on human mast cells and basophilsDubravka Smiljkovic, Harald Herrmann, Irina Sadovnik, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Antioxidants (Basel, Switzerland)|February 24, 2024
The Antioxidant and Anti-Inflammatory Properties of Wild Bilberry Fruit Extracts Embedded in Mesoporous Silica-Type Supports: A Stability StudyAna-Maria Brezoiu, Mihaela Deaconu, Raul-Augustin Mitran, et al.
Antioxidants (Basel, Switzerland)|August 7, 2020
Effect of Nanoconfinement of Polyphenolic Extract from Grape Pomace into Functionalized Mesoporous Silica on Its Biocompatibility and Radical Scavenging ActivityAna-Maria Brezoiu, Laura Bajenaru, Daniela Berger, et al.
Nanoscale|August 24, 2022
Evaluation of intracellular distribution of folate functionalized silica nanoparticles using fluorescence and hyperspectral enhanced dark field microscopyLuminita Claudia Miclea, Mona Mihailescu, Nicolae Tarba, et al.
Pharmaceutics|September 5, 2020
Biological Evaluation of Black Chokeberry Extract Free and Embedded in Two Mesoporous Silica-Type MatricesValentina Buda, Ana-Maria Brezoiu, Daniela Berger, et al.
Veterinary and Comparative Oncology|April 12, 2017
The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytomaAlexandra Keller, Bettina Wingelhofer, Barbara Peter, et al.
Oncotarget|October 6, 2017
The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cellsGabriele Stefanzl, Daniela Berger, Sabine Cerny-Reiterer, et al.
Leukemia|March 15, 2023
Engraftment in NSG<sub>SCF</sub> mice correlates with the WHO category and prognosis in systemic mastocytosisMichael Willmann, Barbara Peter, Katharina Slavnitsch, et al.
American Journal of Cancer Research|October 18, 2021
Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing <i>BCR-ABL1</i> <sup>T315I</sup>-compound mutationsKaroline V Gleixner, Yüksel Filik, Daniela Berger, et al.
Leukemia|April 7, 2019
Identification of a leukemia-initiating stem cell in human mast cell leukemiaGregor Eisenwort, Irina Sadovnik, Juliana Schwaab, et al.
The Journal of Allergy and Clinical Immunology|August 11, 2022
Expression and regulation of Siglec-6 (CD327) on human mast cells and basophilsDubravka Smiljkovic, Harald Herrmann, Irina Sadovnik, et al.
Pageof 6